Literature DB >> 20655380

Easy genotyping of complement C3 'slow' and 'fast' allotypes by tetra-primer amplification refractory mutation system PCR.

Benedetta Peruzzi1, Martina Serra, Chiara Pescucci, Michela Sica, Sonia Lastraioli, Tommaso Rondelli, Simona Pedemonte, Antonio Maria Risitano, Maria De Angioletti, Patrizia Piccioli, Rosario Notaro.   

Abstract

Complement C3 'slow' and 'fast' allotypes are associated with immune-mediated disorders and may affect the outcome of renal transplantation. We report a tetra-primer amplification refractory mutation system PCR (T-ARMS-PCR) that provides a rapid, reproducible and cost-effective method to genotype both complement C3 'slow' and 'fast' alleles by a single tube reaction.
Copyright © 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20655380     DOI: 10.1016/j.mcp.2010.07.002

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  3 in total

1.  Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Tommaso Rondelli; Antonio M Risitano; Régis Peffault de Latour; Michela Sica; Benedetta Peruzzi; Patrizia Ricci; Wilma Barcellini; Anna Paola Iori; Carla Boschetti; Veronica Valle; Veronique Frémeaux-Bacchi; Maria De Angioletti; Gerard Socie; Lucio Luzzatto; Rosario Notaro
Journal:  Haematologica       Date:  2013-09-13       Impact factor: 9.941

2.  Analysis of C3 Gene Variants in Patients With Idiopathic Recurrent Spontaneous Pregnancy Loss.

Authors:  Frida C Mohlin; Piet Gros; Eric Mercier; Jean-Christophe Raymond Gris; Anna M Blom
Journal:  Front Immunol       Date:  2018-08-07       Impact factor: 7.561

3.  A novel multiplex tetra-primer ARMS-PCR for the simultaneous genotyping of six single nucleotide polymorphisms associated with female cancers.

Authors:  Chen Zhang; Ying Liu; Brian Z Ring; Kai Nie; Mengjie Yang; Miao Wang; Hongwei Shen; Xiyang Wu; Xuejun Ma
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.